The chemical class termed RGD1560436 Activators encompasses a range of compounds that are known to interact with various signaling pathways within cellular contexts, thereby modulating the activity of RGD1560436. These activators are not specific to a singular mode of action but rather represent a diverse array of mechanisms by which they can influence the protein's function. The activators typically work by altering the concentration of intracellular messengers or by modifying the activity of kinases, phosphatases, or other enzymes that directly or indirectly modulate the function of RGD1560436. Some of these chemicals achieve this by binding to receptors or other cellular components, leading to a cascade of events that culminate in the modulation of RGD1560436 activity.
The primary role of these activators is to modulate signal transduction processes. They can either enhance or diminish the activity of the targeted protein, depending on the nature of the interaction and the cellular context. Such activators can alter the dynamics of second messengers like cAMP or calcium, which are critical in numerous pathways and can thereby influence the activity of RGD1560436. Others may interact with kinases that phosphorylate specific proteins, including RGD1560436, changing their conformation and activity. Additionally, some activators may inhibit phosphatases, leading to an increased level of phosphorylation and a sustained activation of proteins. The specific interaction between an activator and its cellular target is precise, relying on the unique molecular structure of the activator to achieve the desired modulation of RGD1560436.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, preventing cAMP degradation, which could possibly activate Airim by sustaining cAMP-dependent pathways if Airim is influenced by those pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which could possibly activate Airim if Airim is downstream of PKC signaling. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium levels, which could possibly activate Airim by affecting calcium-dependent signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which could possibly activate Airim by altering MAPK/ERK pathway activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which could possibly activate Airim by impacting proteins modulated by p38 MAPK activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which could possibly activate Airim by changing AKT signaling pathway activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which could possibly activate Airim by affecting proteins involved in mTOR-regulated processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Non-selectively inhibits kinases, which could possibly activate Airim by altering kinase-dependent signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, which could possibly activate Airim by leading to changes in the MAPK/ERK signaling pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Acts as a calcium chelator, which could possibly activate Airim by reducing intracellular calcium levels and affecting calcium signaling. | ||||||